MYCELX Technologies Corporation
MYX.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £1,670 | £1,403 | £3,500 | £5,339 |
| % Growth | 19% | -59.9% | -34.4% | – |
| Cost of Goods Sold | £974 | £1,045 | £2,514 | £3,966 |
| Gross Profit | £696 | £358 | £986 | £1,373 |
| % Margin | 41.7% | 25.5% | 28.2% | 25.7% |
| R&D Expenses | £105 | £106 | £113 | £141 |
| G&A Expenses | £2,525 | £2,550 | £2,885 | £3,128 |
| SG&A Expenses | £2,550 | £2,574 | £2,892 | £3,135 |
| Sales & Mktg Exp. | £25 | £24 | £7 | £7 |
| Other Operating Expenses | £109 | £105 | £107 | £115 |
| Operating Expenses | £2,764 | £2,785 | £3,112 | £3,391 |
| Operating Income | -£2,068 | -£2,427 | -£2,126 | -£2,018 |
| % Margin | -123.8% | -173% | -60.7% | -37.8% |
| Other Income/Exp. Net | £154 | £1,084 | £831 | -£5 |
| Pre-Tax Income | -£1,914 | -£1,343 | -£1,295 | -£2,023 |
| Tax Expense | £1 | £19 | £66 | £178 |
| Net Income | -£1,915 | -£1,362 | -£1,361 | -£2,201 |
| % Margin | -114.7% | -97.1% | -38.9% | -41.2% |
| EPS | -0.079 | -0.06 | -0.06 | -0.096 |
| % Growth | -31% | 0% | 37.4% | – |
| EPS Diluted | -0.08 | -0.06 | -0.059 | -0.096 |
| Weighted Avg Shares Out | 23,938 | 22,700 | 22,684 | 22,983 |
| Weighted Avg Shares Out Dil | 24,364 | 23,876 | 22,983 | 22,983 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £5 |
| Interest Expense | £5 | £6 | £7 | £0 |
| Depreciation & Amortization | £156 | £163 | £235 | £427 |
| EBITDA | -£1,912 | -£2,264 | -£1,891 | -£1,591 |
| % Margin | -114.5% | -161.4% | -54% | -29.8% |